Ascendis Pharma A/S
NASDAQ:ASND
Ascendis Pharma A/S
NASDAQ:ASND
Price:
220.86
USD
2.47%
Market Cap:
$13.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Ascendis Pharma A/S
NASDAQ:ASND
|
DK |
|
IPG Photonics Corp
NASDAQ:IPGP
|
US |
|
R
|
Ritamix Global Ltd
HKEX:1936
|
MY |
Relative Value
The Relative Value of one
ASND
stock under the Base Case scenario is
194.73
USD.
Compared to the current market price of 220.86 USD,
Ascendis Pharma A/S
is
Overvalued by 12%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ASND
Relative Value
Base Case
194.73
USD
Overvaluation 12%
Multiples Across Competitors
ASND Competitors Multiples
Ascendis Pharma A/S Competitors
Ascendis Pharma A/S Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DK |
|
Ascendis Pharma A/S
NASDAQ:ASND
|
13.4B USD | 16 | -50.6 | -95.9 | -83.5 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.8B USD | 6 | 87.7 | 14.6 | 20.2 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.8B USD | 5.2 | 24.8 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.4B USD | 5.9 | 20.3 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.9B USD | 9.7 | 29.5 | 22.2 | 23.2 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.4B USD | 5.5 | 17.6 | 13.1 | 14.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.2B AUD | 3.1 | 34.4 | 11.4 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
35.7B EUR | 10.4 | 33.5 | 36.3 | 37 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
